Anti-inflammatory activity of ivermectin in late-stage COVID-19 may reflect activation of systemic glycine receptors | Open Heart

Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Archive

Authors

About
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

XML

Editorial

Anti-inflammatory activity of ivermectin in late-stage COVID-19 may reflect activation of systemic glycine receptors

Online download statistics by month:

Online download statistics by month: April 2021 to March 2023

	Abstract	Full	Pdf
Apr 2021	1848	1852	438
May 2021	1375	1369	203
Jun 2021	1002	990	174
Jul 2021	967	971	114
Aug 2021	1931	1925	218
Sep 2021	9757	9739	1051
Oct 2021	2899	2892	672
Nov 2021	726	724	101
Dec 2021	1743	1747	85
Jan 2022	1742	1750	142
Feb 2022	1526	1501	81
Mar 2022	850	837	78
Apr 2022	1061	1017	69
May 2022	754	747	55
Jun 2022	745	730	28
Jul 2022	576	575	45
Aug 2022	452	449	45
Sep 2022	672	674	46
Oct 2022	544	544	53
Nov 2022	896	894	32
Dec 2022	3349	3354	52
Jan 2023	7944	7949	118
Feb 2023	8697	8698	111
Total	52056	51928	4011